2025-11-14T15:10:48-06:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP 10700 NORTHUP WAY SUITE 200 BELLEVUE WA 98004 990 2024-01-01 990257883 HAWAII ORGAN PROCUREMENT ORGANIZATION HAWA 8085997630 405 N KUAKINI STREET 810 HONOLULU HI 96817 LEONARD LICINA PRESIDENT & CEO 8085997630 2025-11-13 1 0 KURT BENNION CPA P01469618 4252506100 2025-11-13 2024 2025-03-06 01:10:19Z LEGACY OF LIFE HAWAII LEONARD LICINA 405 N KUAKINI STREET 810 HONOLULU HI 96817 7597340 0 X WWW.LEGACYOFLIFEHAWAII.ORG X 1987 HI THE MISSION OF LEGACY OF LIFE HAWAI'I IS TO SAVE AND ENHANCE LIVES THROUGH RECOVERING ORGANS AND TISSUE FOR TRANSPLANT; ENCOURAGE ORGAN DONATION THROUGH COMMUNITY OUTREACH AND EDUCATION; AND HONOR AND SUPPORT ORGAN DONORS AND THEIR FAMILIES. 11 11 49 34 0 0 138937 13864 6818270 7518610 43151 64866 0 0 7000358 7597340 0 0 0 0 3076011 3346057 0 0 0 3481850 3634840 6557861 6980897 442497 616443 7366443 7812765 2300205 2038352 5066238 5774413 THE MISSION OF LEGACY OF LIFE HAWAI'I IS TO SAVE AND ENHANCE LIVES THROUGH RECOVERING ORGANS AND TISSUE FOR TRANSPLANT; ENCOURAGE ORGAN DONATION THROUGH COMMUNITY OUTREACH AND EDUCATION; AND HONOR AND SUPPORT ORGAN DONORS AND THEIR FAMILIES 0 0 6020588 0 7518610 PROCUREMENT OF ORGANS AND TISSUES FOR TRANSPLANT AND RESEARCH. IN 2024, THE ORGANIZATION RECOVERED 123 ORGANS FROM 58 DONORS RESULTING IN 123 LIFE-SAVING TRANSPLANTS AND RECOVERED TISSUES FROM 124 DONORS. 3,800 PARTICIPANTS IN HEALTH FAIRS / VIRTUAL FAIRS PRESENTED TO 50 DIFFERENT COMMUNITY GROUPS AND DISTRIBUTED 220 PACKETS OF INFORMATION. 6020588 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 21 0 1 49 1 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 HI X DANIELLE TAKETA 8085997630 405 N KUAKINI STREET 110 HONOLULU HI 96817 LEONARD LICINA PRESIDENT & CEO 40.00 X 244328 0 64620 FELICIA WELLS-WILLIAMS DIRECTOR OF CLINICAL SERVICES 40.00 X 180464 0 61141 PAULA TARKINGTON PROCUREMENT TRANSPLANT COORDINATOR 40.00 X 147559 0 31804 HUGH DOYLE PROCUREMENT TRANSPLANT COORDINATOR 40.00 X 145052 0 21624 GINA BRAGIEL PROCUREMENT TRANSPLANT COORDINATOR 40.00 X 135604 0 26044 MARGARET PUTHOFF PROCUREMENT TRANSPLANT COORDINATOR 40.00 X 142365 0 18152 SHERWOOD DEJOIE PROCUREMENT TRANSPLANT COORDINATOR 40.00 X 132098 0 19526 REBECCA GENTRUP MANAGER OF TISSUE PROCUREMENT 40.00 X 123521 0 16579 DANIELLE TAKETA ACCOUNTING & H.R. MANAGER 40.00 X 83302 0 29126 PATRICK DUARTE CHAIR 1.00 X X 0 0 0 LEIGH-ANN MIYASATO VICE CHAIR 1.00 X X 0 0 0 SEAN KEONI CRAIG SECRETARY 1.00 X X 0 0 0 TERRI FUJII TREASURER 1.00 X X 0 0 0 SUZANNE EUGENIO DIRECTOR 0.50 X 0 0 0 DONNA LEE-ROBELLO DIRECTOR 0.50 X 0 0 0 CREIGHTON LIU DIRECTOR 0.50 X 0 0 0 BERYL MUNIZ RN MAS DIRECTOR 0.50 X 0 0 0 SHEN REN DIRECTOR 0.50 X 0 0 0 PALANI SMITH DIRECTOR 0.50 X 0 0 0 JOHN YAMAGUCHI MD DIRECTOR 0.50 X 0 0 0 1334293 0 288616 9 0 1 0 THE QUEEN'S MEDICAL CENTER 1301 PUNCHBOWL STREET 303 HONOLULU HI 96813 MEDICAL SERVICES 598751 EUROFINS VRL PO BOX 1469 CAROL STREAM IL 601321469 LABORATORY SERVICES 448366 INVITA HEALTHCARE TECHNOLOGIES 180 W OSTEND ST STE 267A BALTIMORE MD 21230 ELECTRONIC RECORDS ADMINISTRATION 177713 STATLINE PO BOX 417946 BOSTON MA 022417946 CALL CENTER & DONOR REGISTRY SERVICES 153578 MAUI MEMORIAL MEDICAL CENTER 221 MAHALANI STREET WAILUKU HI 96793 HOSPITAL FEE 114890 6 13864 13864 ORGAN PROCURMENT 900099 7518610 7518610 7518610 64866 64866 7597340 7518610 0 64866 803081 803081 2252492 2111941 140551 75945 75945 214539 173321 41218 76039 38290 37749 41040 41040 460297 411633 48664 6603 6603 123904 115198 8706 143435 143435 40838 40838 85919 34142 51777 15880 15880 73288 44038 29250 387583 370405 17178 OTHER DIRECT EXPENSES 1822164 2107728 -285564 CREDIT LOSS 192348 192348 OTHER EXPENSES 62541 60476 2065 DUES AND SUBSCRIPTIONS 60079 54985 5094 42882 23382 19500 6980897 6020588 960309 0 1065186 2342483 20100 0 2145430 1221471 168022 158769 2010234 814168 1189401 1196066 2289527 2405686 488777 488290 7366443 7812765 1281770 1070868 50000 40000 472199 431248 496236 496236 2300205 2038352 X 4590205 5267188 476033 507225 5066238 5774413 7366443 7812765 616443 91732 0 X 0 1 X 1 0 X 96251 506801 233150 138937 13864 989003 6305258 6783497 6969034 6818270 7518610 34394669 6401509 7290298 7202184 6957207 7532474 35383672 66667 5000 71667 0 66667 5000 71667 35312005 4946 19486 11297 43151 64866 143746 4946 19486 11297 43151 64866 143746 64342 5791 70133 6470797 7315575 7213481 7000358 7597340 35597551 0.99200 0.98570 0.00400 0.00280 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: RESEARCH INCOME MISCELLANEOUS INCOME FUNDRAISING EVENT REVENUES 468044 18108 12480 498632 417121 37894 13029 468044 375448 100125 -58452 417121 215849 152064 7535 375448 113520 108817 -6488 215849 0.00000 1.00000 0.00000 0 0 1221308 431545 789763 545884 192886 352998 243042 189737 53305 1196066 UNEMPLOYMENT TRUST FUND 72144 RIGHT-OF-USE LEASE ASSETS 416146 488290 RIGHT-OF-USE LEASE LIABILITIES 496236 496236 X 7628532 91732 91732 7536800 41040 19500 60540 7597340 6920357 0 6920357 41040 19500 60540 6980897 PART V, LINE 4: IN 2019, LEGACY OF LIFE HAWAII ESTABLISHED THE LIVINGSTON M.F. WONG, MD, FASC ENDOWMENT FUND TO PROVIDE THE LEGACY OF LIFE HAWAII WITH PERPETUAL FINANCIAL SUPPORT FOR PUBLIC EDUCATION AND OUTREACH. PART X, LINE 2: LLH IS RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS AN EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. LLH RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF A TAX POSITION ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION AFTER AN AUDIT BASED ON THE TECHNICAL MERITS OF THE POSITION. LLH HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS IN FILED RETURNS THAT REQUIRE DISCLOSURE IN THE ACCOMPANYING FINANCIAL STATEMENTS. EXCEPT FOR INCOME TAX ON NET INCOME THAT IS DERIVED FROM BUSINESS ACTIVITIES THAT ARE UNRELATED TO ITS EXEMPT PURPOSE, LLH IS NOT SUBJECT TO INCOME TAXES IN THE U.S. FEDERAL JURISDICTION AND THE STATE. TAX REGULATIONS WITHIN EACH JURISDICTION ARE SUBJECT TO INTERPRETATION OF THE RELATED TAX LAWS AND REGULATIONS AND REQUIRE SIGNIFICANT JUDGMENT TO APPLY. PART XI, LINE 4B - OTHER ADJUSTMENTS: BAD PLEDGE EXPENSE 19,500. PART XII, LINE 4B - OTHER ADJUSTMENTS: BAD PLEDGE EXPENSE 19,500. X 1 1 X X X 0 0 0 0 0 1 0 0 0 LEONARD LICINA PRESIDENT & CEO 236860 0 7468 0 0 0 30500 0 34120 0 308948 0 0 0 FELICIA WELLS-WILLIAMS DIRECTOR OF CLINICAL SERVICES 174470 0 5994 0 0 0 28892 0 32249 0 241605 0 0 0 PAULA TARKINGTON PROCUREMENT TRANSPLANT COORDINATOR 147559 0 0 0 0 0 21210 0 10594 0 179363 0 0 0 HUGH DOYLE PROCUREMENT TRANSPLANT COORDINATOR 142592 0 2460 0 0 0 8755 0 12869 0 166676 0 0 0 GINA BRAGIEL PROCUREMENT TRANSPLANT COORDINATOR 133272 0 2332 0 0 0 13773 0 12271 0 161648 0 0 0 MARGARET PUTHOFF PROCUREMENT TRANSPLANT COORDINATOR 139969 0 2396 0 0 0 0 0 18152 0 160517 0 0 0 SHERWOOD DEJOIE PROCUREMENT TRANSPLANT COORDINATOR 129843 0 2255 0 0 0 12573 0 6953 0 151624 0 0 0 PART I, LINE 1A DURING 2024, THE ORGANIZATION GAVE GIFT CARDS WORTH $50 - $125 TO ALL EMPLOYEES. EMPLOYEE COMPENSATION WAS GROSSED UP TO COVER THE TAXES ON THE VALUE OF THE GIFT CARD. PART I, LINE 6 THE ORGANIZATION HAS AN INCENTIVE COMPENSATION PROGRAM FOR ALL EXEMPT EMPLOYEES. THE ORGANIZATION'S NET INCOME IS A QUALIFYING FACTOR IN DETERMINING WHETHER ANY INCENTIVE COMPENSATION WILL BE PAID OUT FOR THE YEAR. HOWEVER, IT IS NOT A FACTOR IN DETERMINING THE AMOUNT PAID. FACTORS IN DETERMINING THE AMOUNT OF INCENTIVE COMPENSATION INCLUDE ORGAN DONORS, KIDNEY TRANSPLANTS, TISSUE DONORS AND TISSUE GRAFTS. FORM 990, PART VI, SECTION A, LINE 1A THE BOARD OF DIRECTORS HAS AN EXECUTIVE COMMITTEE CONSISTING OF THE OFFICERS OF THE BOARD AND THE IMMEDIATE PAST CHAIR OF THE BOARD. THE EXECUTIVE COMMITTEE HAS ALL POWER AND AUTHORITY OF THE BOARD OF DIRECTORS TO ACT IN URGENT OR EMERGENT SITUATIONS ON BEHALF OF THE BOARD, AND REPORTS TO THE BOARD REGARDING ACTIONS TAKEN AT THE NEXT REGULARLY SCHEDULED MEETING TO ENSURE ACCOUNTABILITY OF THE EXECUTIVE COMMITTEE TO THE BOARD, EXCEPT THAT THE EXECUTIVE COMMITTEE DOES NOT HAVE THE POWER TO DO ANY OF THE FOLLOWING: 1. APPROVE THE ORGANIZATION'S DISSOLUTION OR MERGER OR THE SALE, PLEDGE, OR TRANSFER OF ALL OR SUBSTANTIALLY ALL OF THE ORGANIZATION'S ASSETS; 2. ELECT, APPOINT, OR REMOVE DIRECTORS OR FILL VACANCIES ON THE BOARD OR ANY OF ITS COMMITTEES; 3. AMEND, ALTER OR REPEAL ANY RESOLUTION OF THE BOARD OF DIRECTORS; 4. ADOPT, AMEND, OR REPEAL THE ARTICLES OF INCORPORATION OR BY-LAWS; 5. MAKE AN EXPENDITURE OR INCUR ANY OBLIGATION BY OR ON BEHALF OF THE ORGANIZATIONAT ANY ONE TIME INVOLVING A SUM IN EXCESS OF $100,000, INCLUDING BY ANY LEASE OR INSTALLMENT CONTRACT WHERE THE TOTAL AMOUNT OF ALL FUTURE PAYMENTS EXCEEDS $100,000; OR 6. APPROVE A TRANSACTION OR CONTRACT WHICH INVOLVES, DIRECTLY OR INDIRECTLY, A MEMBER OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B PRIOR TO FILING, A DRAFT OF THE FORM 990 WAS REVIEWED BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, THEN PROVIDED TO ALL MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY CONSIDERS ALL DIRECTORS, OFFICERS AND MEMBERS OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAVE A DIRECT OR INDIRECT FINANCIAL INTEREST AS AN INTERESTED PERSON. INTERESTED PERSONS MUST COMPLETE A DISCLOSURE FORM ANNUALLY AND ANYTIME ACTUAL OR POSSIBLE CONFLICTS OF INTEREST MAY OCCUR. INTERESTED PERSONS MUST DISCLOSE THE EXISTENCE OF HIS OR HER FINANCIAL INTEREST AND ALL MATERIAL FACTS TO THE BOARD OF DIRECTORS AND MEMBERS OF COMMITTEES WITH BOARD DELEGATED POWERS. AFTER DISCLOSURE BY THE INTERESTED PERSON, THE DETERMINATION OF A CONFLICT IS DISCUSSED AND VOTED ON. IF A CONFLICT OF INTEREST EXISTS THE INTERESTED PERSON MAY MAKE A PRESENTATION REGARDING THE TRANSACTION OR THE CHAIRPERSON MAY APPOINT A DISINTERESTED PERSON TO INVESTIGATE ALTERNATIVES TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE EVALUATES THE PRESIDENT AND CHIEF EXECUTIVE OFFICER'S COMPENSATION. THE EXECUTIVE COMMITTEE USES A NATIONAL SALARY SURVEY THAT IS COMPLETED BY ALL ORGAN PROCUREMENT ORGANIZATIONS TO DETERMINE SALARY RANGES FOR THE INDUSTRY. COMPENSATION GRADES AND RANGES ARE DETERMINED BY USING LOCAL AND NATIONAL SALARY SURVEYS AS WELL AS THE ANNUAL ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATION SURVEY AND REFLECT EXPERIENCE, TRAINING AND SCOPE OF JOB AND ORGANIZATIONAL RESPONSIBILITIES. A RECOMMENDATION IS MADE TO THE EXECUTIVE COMMITTEE WHO DETERMINES THE PRESIDENT AND CHIEF EXECUTIVE OFFICER'S COMPENSATION. THE PROCESS LAST INCLUDED REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION IN 2024. THE PRESIDENT AND CHIEF EXECUTIVE OFFICER IS RESPONSIBLE FOR PERFORMING ANNUAL EVALUATIONS AND APPROVING COMPENSATION FOR ALL OTHER EMPLOYEES. THE PROCESS LAST INCLUDED COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION IN 2024. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST AT THE ORGANIZATION'S OFFICE.